Viatris (VTRS) Gains from Investment Securities (2020 - 2026)

Viatris (VTRS) recorded quarterly Gains from Investment Securities of $82.0 million in Q1 2026, up 1476.92% quarter-over-quarter from $5.2 million in Q4 2025, and up 140.24% on a YoY basis from $34.1 million in Q1 2025.

Viatris (VTRS) Gains from Investment Securities (2020 - 2026) Analysis & Trends

Viatris' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $82.0 million for Q1 2026.

  • In Q1 2026, Gains from Investment Securities rose 140.24% year-over-year to $82.0 million; the TTM figure through Mar 2026 stood at $321.3 million (up 274.62% YoY), while the FY2025 annual figure was $35.5 million, up 70.67% from the prior year.
  • Gains from Investment Securities was $82.0 million for Q1 2026 at Viatris, up from $5.2 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $756.6 million in Q3 2025 to a low of -$522.5 million in Q2 2025.
  • Historically, Gains from Investment Securities has averaged -$11.7 million across 5 years, with a median of $9.9 million in 2022.
  • The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities surged 1706.06% in 2023, then tumbled 20480.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$459.1 million in 2022, then soared by 109.89% to $45.4 million in 2023, then plunged by 451.98% to -$159.8 million in 2024, then soared by 103.25% to $5.2 million in 2025, then surged by 1476.92% to $82.0 million in 2026.
  • The last three Gains from Investment Securities figures came in at $82.0 million (Q1 2026), $5.2 million (Q4 2025), and $756.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn
10 Viatris - - 1.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 82.00 Mn
Mar 31, 2026 82.00 Mn
Dec 31, 2025 5.20 Mn
Dec 31, 2025 5.20 Mn
Sep 30, 2025 756.60 Mn
Sep 30, 2025 756.60 Mn
Jun 30, 2025 -522.50 Mn
Jun 30, 2025 -522.50 Mn
Mar 31, 2025 -203.80 Mn
Mar 31, 2025 -203.80 Mn
Dec 31, 2024 -159.80 Mn
Dec 31, 2024 -159.80 Mn
Sep 30, 2024 168.90 Mn
Sep 30, 2024 168.90 Mn
Jun 30, 2024 10.70 Mn
Jun 30, 2024 10.70 Mn
Mar 31, 2024 1.00 Mn
Mar 31, 2024 1.00 Mn
Dec 31, 2023 45.40 Mn
Dec 31, 2023 45.40 Mn